May 23, 2023
A New York bankruptcy judge approved a $397 million sale of Purdue Pharma's over-the-counter drug business Tuesday, but unsecured creditors say they are concerned about the potential delay in having the proceeds from the transaction distributed by the debtor.
April 25, 2023
A New York bankruptcy judge gave pharmaceutical maker Purdue Pharma permission Tuesday to put its over-the-counter business on the auction block next month with a $397 million stalking horse bid.
April 06, 2023
Purdue Pharma is seeking permission from a New York bankruptcy judge to put its over-the-counter business up for auction with a $397 million stalking horse bid from a subsidiary of Arcadia Consumer Healthcare.
January 24, 2023
Purdue Pharma LP urged a New York bankruptcy court on Tuesday to reject a demand from an Indigenous tribe in Canada to lift a freeze on litigation against the bankrupt drugmaker and its Sackler family owners so the tribe can pursue its claims against the Sacklers in state court.
November 10, 2022
McKinsey & Co. is seeking to move a pair of New York state court suits over its alleged role in Purdue Pharma's opioid marketing efforts to bankruptcy court, saying there is a "strong interconnection" between the cases and Purdue's Chapter 11 case.
June 21, 2022
Cosmetics behemoth Revlon Inc. filed for bankruptcy in the midst of a liquidity crisis, a South American airline brings its Chapter 11 plan in for a landing, and the next phase in Puerto Rico's restructuring nears a creditor vote. This is the week in bankruptcy.
June 15, 2022
A New York bankruptcy judge on Wednesday wound down more than two and a half years presiding over Purdue Pharma LP's contentious Chapter 11 with a ruling approving a trimmed-down incentive payment package for the opioid maker's CEO.
May 24, 2022
Three Roman Catholic dioceses are pushing for approvals of settlements for hundreds of sexual abuse claims in bankruptcy courts, a Delaware state court judge denied a litigation stay in a nonbankruptcy wind-down case, potentially signaling a crackdown, and Purdue Pharma executives got their bonuses approved. This is the week in bankruptcy.
May 18, 2022
Timing adjustments and tweaks defused the limited objections to a $33.8 million bonus package for key employees of bankrupt Purdue Pharma LP, with the plan winning approval Wednesday from a federal bankruptcy judge in the Southern District of New York.
May 17, 2022
Two dozen states objected to proposed bonus payments for the CEO of bankrupt drugmaker Purdue Pharma, the First Circuit declined to rehear an appeal over changes made to Puerto Rican teacher pensions as part of the island's restructuring, and Affordable Care Act penalties are taxes in bankruptcy court. This is the week in bankruptcy.